Drug Type Small molecule drug |
Synonyms 2-Acetamido-2-deoxy-D-glucose, aldehydo-N-acetyl-D-glucosamine, D-GlcNAc + [2] |
Target |
Mechanism ELA2 inhibitors(Leukocyte elastase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
RegulationOrphan Drug (US) |
Molecular FormulaC8H15NO6 |
InChIKeyMBLBDJOUHNCFQT-LXGUWJNJSA-N |
CAS Registry7512-17-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | N-acetylglucosamine | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Irritable bowel syndrome with diarrhea | Phase 3 | CN | 15 Oct 2015 | |
Irritable bowel syndrome with diarrhea | Phase 3 | CN | 15 Oct 2015 | |
Irritable bowel syndrome with diarrhea | Phase 3 | CN | 15 Oct 2015 | |
Muscular Dystrophies | Discovery | US | - |